Evidence map›Paper›PMID 40681343›Full record

ArticleTobacco control2025

Tobacco industry efforts to harness the voice and influence of community organisations.

Tanner D Wakefield, Rosendo Iniguez, Stella Bialous, Pamela Ling, Dorie E Apollonio

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tanner D WakefieldSchool of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID http://orcid.org/0000-0002-4434-3983
Rosendo IniguezCalifornia State University Fresno, Fresno, California, USA.
Stella BialousSchool of Nursing, University of California San Francisco, San Francisco, California, USA.ORCID http://orcid.org/0000-0002-6471-5457
Pamela LingSchool of Medicine, University of California San Francisco, San Francisco, California, USA.
Dorie E ApollonioSchool of Pharmacy, University of California San Francisco, San Francisco, California, USA dorie.apollonio@ucsf.edu.ORCID http://orcid.org/0000-0003-4694-0826

Funding

Addressing disparities in tobacco-related diseases by understanding the tobacco industry strategiesR01CA268491 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STELLA AGUINAGA BIALOUS, Pamela May Ling · 2022 to 2026
$3.4M
NCI NIH HHS R01 CA268491
6 · The paper itself

Abstract

backgroundThe tobacco industry historically recruited community groups to advance its policy agenda; however, there has been little study of industry recruitment of Latinx organisations.

methodsWe reviewed internal tobacco industry documents to identify activities, messaging and strategies used by the Tobacco Institute to obtain political support from a prominent Latinx organisation in the USA. Documents were identified through keyword searches, organised in a spreadsheet and analysed for content.

resultsFrom 1984 to 1989, the Tobacco Institute funded the League of United Latin American Citizens (LULAC) to support its policy agenda. The Tobacco Institute hired organisation leaders, used a public relations firm to plan activities, crafted messages to encourage Latinx support and provided funding to strengthen relationships with LULAC. This encouraged LULAC to actively support the tobacco industry's positions while obscuring industry involvement.

conclusionsThe Tobacco Institute used tactics identified in previous research on third-party industry allies to build a partnership with LULAC. Tobacco companies use similar practices in the 21st century. Our findings suggest a need for transparency regarding industry funding of community organisations given its potential to influence them in ways that promote health harms.

Indexed as

Priority/special populationsPublic policyTaxationTobacco industryTobacco industry documents

Identifiers

PMID40681343
PMCPMC12363563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.